irsogladine has been researched along with mocetinostat in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitazawa, S; Kyoi, T; Tajima, K; Ukai, Y; Zhang, X | 1 |
| Amagase, K; Hatazawa, R; Kamei, K; Kato, N; Kubo, Y; Takeuchi, K | 1 |
| Kageyama, K; Kyoi, T; Tajima, K; Zhang, X | 1 |
3 other study(ies) available for irsogladine and mocetinostat
| Article | Year |
|---|---|
Phosphodiesterase type IV inhibitors prevent ischemia-reperfusion-induced gastric injury in rats.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Anti-Ulcer Agents; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Gastric Mucosa; Male; Omeprazole; Peroxidase; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rolipram; Stomach Ulcer; Triazines; Tumor Necrosis Factor-alpha | 2004 |
Prophylactic effect of irsogladine maleate against indomethacin-induced small intestinal lesions in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Enterobacteriaceae; Gastrointestinal Motility; Ileal Diseases; Indomethacin; Intestinal Diseases; Intestinal Mucosa; Jejunal Diseases; Male; Nitric Oxide Synthase Type II; Peroxidase; Rats; Rats, Sprague-Dawley; Triazines; Ulcer | 2008 |
Irsogladine maleate suppresses indomethacin-induced elevation of proinflammatory cytokines and gastric injury in rats.
Topics: Animals; Anti-Ulcer Agents; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Gastric Mucosa; Indomethacin; Interleukin-1beta; Interleukin-8; Male; Peroxidase; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Rats; Stomach Ulcer; Time Factors; Triazines; Tumor Necrosis Factor-alpha | 2008 |